George Young, MD
Adult Medicine · Jacksonville, FLNPI 1245265677
Payments from drug & device makers
Across 42 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$251
- Shield Therapeutics Inc$155
- AstraZeneca$75
- Novo Nordisk$72
- Noven Therapeutics, LLC$49
- Abbott$44
- plus $227 from 11 others
What the payments were for
- Food & beverage$873100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 12 | $251 |
| Shield Therapeutics Inc | 4 | $155 |
| AstraZeneca | 4 | $75 |
| Novo Nordisk | 5 | $72 |
| Noven Therapeutics, LLC | 2 | $49 |
| Abbott | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Alk-abello, Inc | 1 | $27 |
| Medtronic | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| BD | 1 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Vivus LLC | 1 | $16 |
| Exeltis, USA Inc. | 1 | $14 |
| Corium, LLC | 1 | $3 |
How this compares
$873 in reported general payments places this provider in the 60th percentile of 195 adult medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 14 | $1,117 |
| Levothyroxine Sodium | 75 | $919 |
| Ezetimibe | 34 | $918 |
| Pravastatin Sodium | 25 | $720 |
| Fenofibrate | 36 | $684 |
| Ventolin HfaAlbuterol Sulfate | 11 | $604 |
| Tamsulosin Hcl | 17 | $513 |
| Rosuvastatin Calcium | 40 | $510 |
| Carvedilol | 23 | $387 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $377 |
| Alprazolam | 50 | $334 |
| Losartan Potassium | 28 | $253 |
| Montelukast Sodium | 23 | $249 |
| Cyclobenzaprine Hcl | 32 | $247 |
| Telmisartan | 13 | $224 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Jacksonville
- Juliana LlanoJacksonville$5K
- Brandon HillJacksonville$3K
- Lucky FloresMiami Lakes$4.2M
- Lidia BermudezHialeah$2.6M
- Linda MartinezDoral$2.1M
- Nelson GonzalezMiami$1.6M
- Victor SilvaTampa$1.2M
- Francisco Gonzalez AbreuMiami$774K
- Maria de la TorreMiami$685K
- Steven SantiagoMiami$290K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.